Pictured: Daniel Prince
In the Clinic
By Andrea Peirce, BA, Writer/Editor  |  Wednesday, November 26, 2014

Memorial Sloan Kettering has taken the lead in applying a limb-lengthening technique in people with bone cancer to restore long gaps in bone after removal of a tumor.

Pictured: William Alago
Q&A
By Maureen Salamon, BA, Freelance Writer  |  Monday, November 24, 2014

Interventional radiologist William Alago discusses minimally invasive procedures, advances in imaging techniques, and the future of his field.

Pictured: Jedd Wolchok, Alexandra Snyder Charen and Timothy Chan
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, November 20, 2014

In people with melanoma who respond to the drug ipilimumab, certain mutations make tumors more visible to the immune system.

Michel Sadelain and Prasad Adusumilli
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, November 19, 2014

A study in mouse models suggests how modified T cells may be used to treat tumors in the area just outside the lungs.

Billy Kupferman of Mustaches for Kids and Eve H.
Giving
By Celia Gittelson, BA  |  Tuesday, November 18, 2014

Mustaches for Kids raises funds for Memorial Sloan Kettering’s pediatric patients in a most hairy way.

(From left) MSK investigators Michael Berger, José Baselga, and Maurizio Scaltriti, and graduate student Pau Castel.
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Monday, November 17, 2014

A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.

Gregory Riely
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, November 12, 2014

MSK lung cancer patients benefit from a powerful genomic test that looks for mutations in 341 genes to help determine the best treatment.

Pictured: Joao Xavier & Eric Pamer
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Monday, November 10, 2014

Clostridium difficile infections are a growing problem, but MSK researchers are looking for innovative ways to prevent and treat them.

RISE Program Clinical Director Debra Mangino discusses next steps with a patient.
In the Clinic
By Andrea Peirce, BA, Writer/Editor  |  Friday, October 31, 2014

The team of experts in our RISE Program tailor each woman’s surveillance plan based on the latest findings in breast cancer risk, prevention, and treatment.

David Kanarek, 1996.
Giving
By Celia Gittelson, BA  |  Thursday, October 30, 2014

The death of one courageous young man and the vision and generosity of his parents are making a difference for pediatric cancer patients at the end of life, as well as for their families.

Pictured: Jorge Reis-Filho and Britta Weigelt
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Tuesday, October 28, 2014

Genetic alterations linked to a rare salivary cancer could also shed light on more common malignancies.

Pictured: Kathryn Ciccolini
Support
By Kathryn Ciccolini, RN, BSN, OCN, Clinical Nurse  |  Tuesday, October 28, 2014

Navigating insurance requirements and filling and paying for prescription medications can be a challenge for patients. These tips can ensure your next trip to the pharmacy is a smooth one.

Cancer Care
SUPPORT
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, October 23, 2014

MSK medical oncologist and acupuncturist Ting Bao discusses the symptoms that arise during breast cancer treatment and how integrative medicine may help relieve them.

Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Monday, October 20, 2014

Medical oncologist Paul Sabbatini demystifies common misconceptions surrounding clinical trials.

DNA wrapped around histones
Decoder
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, October 14, 2014

Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer.

Center News

Stay Informed

Get the latest information about cancer care and research every month.